Literature DB >> 2783921

Isolation and characterization of a mutant of Haemophilus influenzae type b deficient in outer membrane protein P1.

R Munson1, A Hunt.   

Abstract

The gene for outer membrane protein P1 of Haemophilus influenzae type b has been previously cloned and expressed in Escherichia coli. To investigate the physiologic role of the P1 protein, the cloned P1 gene was insertionally inactivated with the Tn5 derivative Tn5tac1, and an isogenic P1-deficient Haemophilus mutant was then generated by transformation with linearized plasmid DNA containing the insertionally inactivated gene. The P1-deficient strain grew normally in vitro and induced bacteremia in the infant rat model.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783921      PMCID: PMC313214          DOI: 10.1128/iai.57.3.1002-1004.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Sensitive mutants of bacteriophage lambda.

Authors:  A CAMPBELL
Journal:  Virology       Date:  1961-05       Impact factor: 3.616

2.  Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands.

Authors:  B Lugtenberg; J Meijers; R Peters; P van der Hoek; L van Alphen
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

3.  Purification, cloning, and sequence of outer membrane protein P1 of Haemophilus influenzae type b.

Authors:  R Munson; S Grass
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

4.  Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid.

Authors:  E R Moxon; P T Ostrow
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

5.  Comparison of outer-membrane protein subtypes and biotypes of isolates of Haemophilus influenzae type b.

Authors:  S J Barenkamp; R S Munson; D M Granoff
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

6.  Tn5tac1, a derivative of transposon Tn5 that generates conditional mutations.

Authors:  W Y Chow; D E Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

7.  Subtyping isolates of Haemophilus influenzae type b by outer-membrane protein profiles.

Authors:  S J Barenkamp; R S Munson; D M Granoff
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

8.  Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.

Authors:  J L Shenep; R S Munson; S J Barenkamp; D M Granoff
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

9.  Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

10.  Protection of infant rats from Haemophilus influenzae type b infection by antiserum to purified outer membrane protein a.

Authors:  M R Loeb
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

View more
  12 in total

1.  Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.

Authors:  Scott D Mills; Ann E Eakin; Ed T Buurman; Joseph V Newman; Ning Gao; Hoan Huynh; Kenneth D Johnson; Sushmita Lahiri; Adam B Shapiro; Grant K Walkup; Wei Yang; Suzanne S Stokes
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

2.  Comparative analysis of the structures of the outer membrane protein P1 genes from major clones of Haemophilus influenzae type b.

Authors:  R Munson; S Grass; M Einhorn; C Bailey; C Newell
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach.

Authors:  G R Bolduc; V Bouchet; R Z Jiang; J Geisselsoder; Q C Truong-Bolduc; P A Rice; S I Pelton; R Goldstein
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Characterization of a mutant of Haemophilus influenzae type b lacking the P2 major outer membrane protein.

Authors:  L D Cope; S E Pelzel; J L Latimer; E J Hansen
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  Identification of a surface-exposed immunodominant epitope on outer membrane protein P1 of Haemophilus influenzae type b.

Authors:  C Proulx; R S Munson; S Grass; J Hamel; D Martin; B R Brodeur
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Identification of a Haemophilus influenzae 5'-nucleotidase protein: cloning of the nucA gene and immunogenicity and characterization of the NucA protein.

Authors:  R J Zagursky; P Ooi; K F Jones; M J Fiske; R P Smith; B A Green
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

7.  A novel approach to insertional mutagenesis of Haemophilus influenzae.

Authors:  C Sharetzsky; T D Edlind; J J LiPuma; T L Stull
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

8.  Use of the riboflavin synthase gene (ribC) as a model for development of an essential gene disruption and complementation system for Haemophilus influenzae.

Authors:  Amna Saeed-Kothe; Wei Yang; Scott D Mills
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

9.  Signature-tagged mutagenesis of Pasteurella multocida identifies mutants displaying differential virulence characteristics in mice and chickens.

Authors:  Marina Harper; John D Boyce; Ian W Wilkie; Ben Adler
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Stable, conserved outer membrane epitope of strains of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.

Authors:  A J Lesse; L L Gheesling; W E Bittner; S D Myers; G M Carlone
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.